Investigation of the inhibitory activity of extracts, fractions and secondary metabolites of Silene spp. (Caryophyllaceae) and Serratula cupuliformis (Asteraceae) on the replication of SARS-CoV-2 coronavirus

Aim. In vitro analysis of the inhibitory activity of extracts, fractions and secondary metabolites of plants of the genus Silene [Caryophylaceae] and Serratula cupuliformis [Asteraceae) on the replication of SARS-CoV-2.Material and Methods. Silene spp. and Serratula cupuliformis of the Siberian Botanical Garden of National Research Tomsk State University were used. Ethanol extracts and butanol fractions of Silene spp. were prepared. The flavonoid shaftoside and the ecdysteroid 20-hydroxyecdysone from Lychnis chalcedonica were isolated. Analysis of BAS was carried out by the HPLC method. In vitro analysis of the inhibitory activity of extracts on SARS-CoV-2 replication was performed in Vero cell culture by direct inactivation [neutralization) of virions. Comparison samples were dry ethanol extracts of chaga [Inonotus obliquus, Basidiomycota), spices of cloves [Syzygium aromaticum, Myrtaceae) and root of licorice [Glycyrrhiza glabra L., Fabaceae).Results. The inhibitory activity of ethanol extracts and butanol fractions of Silene spp., as well as individual compounds [shaftozide and 20-E) was revealed in the range of 50% effective concentrations [EC50) when dissolved in water from 339.85±83.92 pg/ml to 1.59±0.39 pg/ml and when dissolved in DMSO from 119.34±26.34 pg/ml to 2.22±0.57 pg/ml, respectively. The butanol fraction of Serratula cupuliformis was active with EC50=21.74±4.80 and 27.42±6.05 pg/mL. These results for some samples of Silene spp. and Serratula cupuliformis are comparable to the EC50 values of the comparators.Conclusion. The results obtained suggest the presence of biologically active substances in the herbal preparations studied that act destructively on virions of SARS-CoV-2 and affect one of the main stages of its "life" cycle - on the attachment to receptors of sensitive cells.

[1]  D. Shaulo,et al.  Inhibitory activity of dry ethanol extracts of Artemisia spp. on SARS‐CoV‐2 replication in vitro , 2022, South of Russia: ecology, development.

[2]  E. Chernyak,et al.  FLAVONOIDS OF SOME PLANT SPECIES OF THE GENERA SILENE , 2022, chemistry of plant raw material.

[3]  A. Hussain A phylogenetic perspective of antiviral species of the genus Artemisia (Asteraceae-Anthemideae): A proposal of anti SARS-CoV-2 (COVID-19) candidate taxa , 2022, Journal of Herbal Medicine.

[4]  P. Buchwald,et al.  Broad-Spectrum Small-Molecule Inhibitors of the SARS-CoV-2 Spike—ACE2 Protein–Protein Interaction from a Chemical Space of Privileged Protein Binders , 2022, Pharmaceuticals.

[5]  T. Shu,et al.  Structures of the SARS-CoV-2 spike glycoprotein and applications for novel drug development , 2022, Frontiers in Pharmacology.

[6]  Hang Yang,et al.  Schaftoside inhibits 3CLpro and PLpro of SARS-CoV-2 virus and regulates immune response and inflammation of host cells for the treatment of COVID-19 , 2022, Acta Pharmaceutica Sinica B.

[7]  S. Jaber,et al.  Apigenin inhibits infectious bronchitis virus replication in ovo. , 2022, European review for medical and pharmacological sciences.

[8]  S. Hayat,et al.  Phytoecdysteroids: Distribution, Structural Diversity, Biosynthesis, Activity, and Crosstalk with Phytohormones , 2022, International journal of molecular sciences.

[9]  M. Magomedov,et al.  Inhibitory activity of tea compositions and their constituent ingredients on SARS‐COV‐2 replication in vitro , 2022, South of Russia: ecology, development.

[10]  M. Hung,et al.  Natural tannins as anti-SARS-CoV-2 compounds , 2022, International journal of biological sciences.

[11]  C. Li,et al.  Antiviral Effect of Polyphenolic Substances in Geranium wilfordii Maxim against HSV-2 Infection Using in vitro and in silico Approaches , 2022, Evidence-based complementary and alternative medicine : eCAM.

[12]  A. Hensel,et al.  Hypericum perforatum and Its Ingredients Hypericin and Pseudohypericin Demonstrate an Antiviral Activity against SARS-CoV-2 , 2022, Pharmaceuticals.

[13]  S. Mironeasa,et al.  Antioxidant, Cytotoxic, and Rheological Properties of Canola Oil Extract of Usnea barbata (L.) Weber ex F.H. Wigg from Călimani Mountains, Romania , 2022, Plants.

[14]  Li Wang,et al.  Plant flavonoids: Classification, distribution, biosynthesis, and antioxidant activity. , 2022, Food chemistry.

[15]  R. Bauer,et al.  SARS-CoV-2 neutralizing activity of polyphenols in a special green tea extract preparation , 2022, Phytomedicine.

[16]  G. Likhatskaya,et al.  Biologically active polyphenolic compounds from Lespedeza bicolor , 2022, Fitoterapia.

[17]  L. Owen,et al.  Antiviral plant‐derived natural products to combat RNA viruses: Targets throughout the viral life cycle , 2021, Letters in applied microbiology.

[18]  T. Alandijany,et al.  Computational and In Vitro Experimental Investigations Reveal Anti-Viral Activity of Licorice and Glycyrrhizin against Severe Acute Respiratory Syndrome Coronavirus 2 , 2021, Pharmaceuticals.

[19]  A. Shestopalov,et al.  IgG Study of Blood Sera of Patients with COVID-19 , 2021, Pathogens.

[20]  Jincun Zhao,et al.  Broad antiviral and anti-inflammatory activity of Qingwenjiere mixture against SARS-CoV-2 and other human coronavirus infections , 2021, Phytomedicine.

[21]  P. Seeberger,et al.  In vitro efficacy of Artemisia extracts against SARS-CoV-2 , 2021, Virology Journal.

[22]  A. Kenarkoohi,et al.  COVID-19-associated opportunistic infections: a snapshot on the current reports , 2021, Clinical and Experimental Medicine.

[23]  T. Giese,et al.  High rate of HSV-1 reactivation in invasively ventilated COVID-19 patients: Immunological findings , 2021, PloS one.

[24]  L. Altucci,et al.  Antiviral Activity of Vitis vinifera Leaf Extract against SARS-CoV-2 and HSV-1 , 2021, Viruses.

[25]  Gengfu Xiao,et al.  Screening of Botanical Drugs against SARS-CoV-2 Entry Reveals Novel Therapeutic Agents to Treat COVID-19 , 2021, bioRxiv.

[26]  L. Dinan,et al.  20-Hydroxyecdysone, from Plant Extracts to Clinical Use: Therapeutic Potential for the Treatment of Neuromuscular, Cardio-Metabolic and Respiratory Diseases , 2021, Biomedicines.

[27]  L. Zibareva,et al.  ECDYSTEROIDS AND FLAVONOIDS OF SILENE GRAEFFERI , 2021 .

[28]  Manas Ranjan Sahoo,et al.  THE RESEARCH UPDATES AND PROSPECTS OF HERBAL HARD-BOILED LOZENGES: A CLASSICAL PLATFORM WITH PROMISING DRUG DELIVERY POTENTIAL , 2021, International Journal of Applied Pharmaceutics.

[29]  Yu Chen,et al.  Coinfection with influenza A virus enhances SARS-CoV-2 infectivity , 2021, Cell Research.

[30]  C. Morélot-Panzini,et al.  Testing the efficacy and safety of BIO101, for the prevention of respiratory deterioration, in patients with COVID-19 pneumonia (COVA study): a structured summary of a study protocol for a randomised controlled trial , 2021, Trials.

[31]  Xiaozhong Peng,et al.  The comprehensive study on the therapeutic effects of baicalein for the treatment of COVID-19 in vivo and in vitro , 2020, Biochemical Pharmacology.

[32]  Niranjan Parajuli,et al.  Potential roles of medicinal plants for the treatment of viral diseases focusing on COVID‐19: A review , 2020, Phytotherapy research : PTR.

[33]  H. Chakraborty,et al.  Entry Inhibitors: Efficient Means to Block Viral Infection , 2020, The Journal of Membrane Biology.

[34]  F. Ceccherini‐Silberstein,et al.  Current status of antivirals and druggable targets of SARS CoV-2 and other human pathogenic coronaviruses , 2020, Drug Resistance Updates.

[35]  H. Keyvani,et al.  Bacterial co‐infections with SARS‐CoV‐2 , 2020, IUBMB life.

[36]  A. Chepurnov,et al.  Antigenic properties of sARs-CoV-2/human/RUs/nsk-FRCFtM-1/2020 coronavirus isolate from a patient in novosibirsk , 2020 .

[37]  V. Patravale,et al.  Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: A review , 2020, Phytomedicine.

[38]  M. Diamond,et al.  Growth, detection, quantification, and inactivation of SARS-CoV-2 , 2020, Virology.

[39]  G. Gao,et al.  Development of an Inactivated Vaccine Candidate, BBIBP-CorV, with Potent Protection against SARS-CoV-2 , 2020, Cell.

[40]  P. Tuchinda,et al.  High-content screening of Thai medicinal plants reveals Boesenbergia rotunda extract and its component Panduratin A as anti-SARS-CoV-2 agents , 2020, Scientific Reports.

[41]  M. Bouachrine,et al.  Moroccan Medicinal plants as inhibitors against SARS-CoV-2 main protease: Computational investigations , 2020, Journal of biomolecular structure & dynamics.

[42]  L. Lai,et al.  Scutellaria baicalensis extract and baicalein inhibit replication of SARS-CoV-2 and its 3C-like protease in vitro , 2020, bioRxiv.

[43]  D. Shin,et al.  Inhibition of SARS-CoV 3CL protease by flavonoids , 2019, Journal of enzyme inhibition and medicinal chemistry.

[44]  A. M. Anishchenko,et al.  Antihyperglycaemic, haemorheological and antioxidant activities of Lychnis chalcedonica L. extract in a streptozotocin-induced rat model of diabetes mellitus , 2019, Journal of complementary & integrative medicine.

[45]  S. Robledo,et al.  In vitro and in silico anti-dengue activity of compounds obtained from Psidium guajava through bioprospecting , 2019, BMC Complementary and Alternative Medicine.

[46]  P. Del Vecchio,et al.  Solvation properties of raft-like model membranes. , 2019, Biochimica et biophysica acta. Biomembranes.

[47]  O. Rybalkina,et al.  Influence of Lychnis chalcedonica L. Flavonoids on Transplanted Tumor Development and Cytostatic Therapy Effectiveness in Mice , 2019, Pharmaceutical Chemistry Journal.

[48]  Khalid Ali Khan,et al.  Role of primary metabolites in plant defense against pathogens. , 2018, Microbial pathogenesis.

[49]  Ziyin Yang,et al.  Understanding the biosyntheses and stress response mechanisms of aroma compounds in tea (Camellia sinensis) to safely and effectively improve tea aroma , 2018, Critical reviews in food science and nutrition.

[50]  K. Berchová‐Bímová,et al.  In Vitro Study of Multi-Therapeutic Properties of Thymus bovei Benth. Essential Oil and Its Main Component for Promoting Their Use in Clinical Practice , 2018, Journal of clinical medicine.

[51]  O. Rybalkina,et al.  Anti-Inflammatory and Analgesic Activities of the Complex of Flavonoids from Lychnis chalcedonica L. , 2017, Bulletin of Experimental Biology and Medicine.

[52]  K. Zandi,et al.  Flavonoids: promising natural compounds against viral infections , 2017, Archives of Virology.

[53]  M. Babushkina,et al.  The effect of Lychnis chalcedonica L. flavonoids on the development of tumors in mice and the effectiveness of treatment with cyclophosphamide , 2015 .

[54]  S. Chandra,et al.  Medicinal plants of the family Caryophyllaceae: a review of ethno-medicinal uses and pharmacological properties , 2015, Integrative medicine research.

[55]  S. Krylova,et al.  Antiulcer Activity of Extracts of Ecdysteroid-Containing Plants of Genera Lychnis and Silene of the Caryophyllaceae Family , 2014, Bulletin of Experimental Biology and Medicine.

[56]  A. Suksamrarn,et al.  Phytoecdysteroids from the Aerial Part of Silene colpophylla , 2014, Chemistry of Natural Compounds.

[57]  M. Wink,et al.  Diversity of Secondary Metabolites in the Genus Silene L. (Caryophyllaceae)—Structures, Distribution, and Biological Properties , 2014 .

[58]  Joana Galvao,et al.  Unexpected low‐dose toxicity of the universal solvent DMSO , 2014, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[59]  L. Dinan,et al.  The phytoecdysteroid profiles of 7 species of Silene (Caryophyllaceae). , 2009, Archives of insect biochemistry and physiology.

[60]  I. Orhan,et al.  Antiviral activity and cytotoxicity of the lipophilic extracts of various edible plants and their fatty acids , 2009 .

[61]  A. Maria,et al.  New minor ecdysteroids from Silene viridiflora , 2004 .